PDE4/MMP inhibitors (Rhone-Poulenc)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePDE4/MMP inhibitors (Rhone-Poulenc)
Drug Alias NameHMR-1571
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 8 inhibitorsMatrix metalloproteinase-2 inhibitorsPhosphodieterase 4 inhibitors +[5] 
TargetsMatrix metalloproteinase 3Matrix metalloproteinase 8Phosphodieterase 4 +[5] 
Therapy Area/IndicationsPsoriasisDermatitis, AtopicAtherosclerosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRhone Poulenc Rorer Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRhone Poulenc Rorer Sa
Active IndicationsN/A
Inactive IndicationsPsoriasisDermatitis, AtopicAtherosclerosis +[5] 

Other Information

ATC CodeN/A
Related LinksN/A